2v22
From Proteopedia
Line 1: | Line 1: | ||
- | [[Image:2v22. | + | {{Seed}} |
+ | [[Image:2v22.png|left|200px]] | ||
<!-- | <!-- | ||
Line 9: | Line 10: | ||
{{STRUCTURE_2v22| PDB=2v22 | SCENE= }} | {{STRUCTURE_2v22| PDB=2v22 | SCENE= }} | ||
- | + | ===REPLACE: A STRATEGY FOR ITERATIVE DESIGN OF CYCLIN BINDING GROOVE INHIBITORS=== | |
- | + | <!-- | |
- | + | The line below this paragraph, {{ABSTRACT_PUBMED_17051658}}, adds the Publication Abstract to the page | |
+ | (as it appears on PubMed at http://www.pubmed.gov), where 17051658 is the PubMed ID number. | ||
+ | --> | ||
+ | {{ABSTRACT_PUBMED_17051658}} | ||
==About this Structure== | ==About this Structure== | ||
Line 20: | Line 24: | ||
==Reference== | ==Reference== | ||
REPLACE: a strategy for iterative design of cyclin-binding groove inhibitors., Andrews MJ, Kontopidis G, McInnes C, Plater A, Innes L, Cowan A, Jewsbury P, Fischer PM, Chembiochem. 2006 Dec;7(12):1909-15. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/17051658 17051658] | REPLACE: a strategy for iterative design of cyclin-binding groove inhibitors., Andrews MJ, Kontopidis G, McInnes C, Plater A, Innes L, Cowan A, Jewsbury P, Fischer PM, Chembiochem. 2006 Dec;7(12):1909-15. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/17051658 17051658] | ||
+ | |||
+ | Differential binding of inhibitors to active and inactive CDK2 provides insights for drug design., Kontopidis G, McInnes C, Pandalaneni SR, McNae I, Gibson D, Mezna M, Thomas M, Wood G, Wang S, Walkinshaw MD, Fischer PM, Chem Biol. 2006 Feb;13(2):201-11. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/16492568 16492568] | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Non-specific serine/threonine protein kinase]] | [[Category: Non-specific serine/threonine protein kinase]] | ||
Line 47: | Line 53: | ||
[[Category: Serine/threonine-protein kinase]] | [[Category: Serine/threonine-protein kinase]] | ||
[[Category: Transferase]] | [[Category: Transferase]] | ||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | |
+ | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 02:57:26 2008'' |
Revision as of 23:57, 27 July 2008
REPLACE: A STRATEGY FOR ITERATIVE DESIGN OF CYCLIN BINDING GROOVE INHIBITORS
Template:ABSTRACT PUBMED 17051658
About this Structure
2V22 is a Protein complex structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.
Reference
REPLACE: a strategy for iterative design of cyclin-binding groove inhibitors., Andrews MJ, Kontopidis G, McInnes C, Plater A, Innes L, Cowan A, Jewsbury P, Fischer PM, Chembiochem. 2006 Dec;7(12):1909-15. PMID:17051658
Differential binding of inhibitors to active and inactive CDK2 provides insights for drug design., Kontopidis G, McInnes C, Pandalaneni SR, McNae I, Gibson D, Mezna M, Thomas M, Wood G, Wang S, Walkinshaw MD, Fischer PM, Chem Biol. 2006 Feb;13(2):201-11. PMID:16492568
Page seeded by OCA on Mon Jul 28 02:57:26 2008
Categories: Homo sapiens | Non-specific serine/threonine protein kinase | Protein complex | Andrews, M J. | Cowan, A. | Fischer, P M. | Innes, L. | Jewsbury, P. | Kontopidis, G. | Mcinnes, C. | Plater, A. | Active | Atp-binding | Cdk2 | Cell cycle | Cell division | Cyclin | Cyclin groove | Inhibition | Kinase | Mitosis | Nonpeptide | Nucleotide-binding | Phosphorylation | Polymorphism | Serine/threonine-protein kinase | Transferase